Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
0.8350
+0.0157 (1.92%)
Jul 29, 2026, 1:59 PM EDT - Market open
RANI Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3.17 | 1.63 | 1.03 | - | - | 2.72 | |
Revenue Growth | 164.08% | 58.85% | - | - | - | 488.10% |
Gross Profit | 3.17 | 1.63 | 1.03 | - | - | 2.72 |
Selling, General & Admin | 19.01 | 19.74 | 23.95 | 26.48 | 26.84 | 27.83 |
Research & Development | 18.8 | 20.21 | 26.68 | 39.62 | 36.61 | 26.48 |
Other Operating Expenses | - | - | 3.71 | - | - | - |
Total Operating Expenses | 37.81 | 39.94 | 54.34 | 66.1 | 63.45 | 54.32 |
Operating Income | -34.64 | -38.31 | -53.31 | -66.1 | -63.45 | -51.6 |
Interest Income | 1.02 | 0.83 | 1.76 | 3.3 | 1.25 | 0.09 |
Interest Expense | -2.04 | -2.89 | -5.03 | -5.09 | -1.07 | -0.47 |
Other Non-Operating Income (Expense) | - | -0.58 | - | - | - | -1.07 |
Total Non-Operating Income (Expense) | -1.02 | -2.64 | -3.27 | -1.78 | 0.18 | -1.45 |
Pretax Income | -36.23 | -40.95 | -56.58 | -67.88 | -63.34 | -53.09 |
Provision for Income Taxes | - | - | - | - | -0.07 | -0.04 |
Net Income | -36.23 | -40.95 | -56.58 | -67.88 | -63.34 | -53.09 |
Minority Interest in Earnings | -6.79 | -11.28 | -26.57 | -33.91 | -32.76 | -44.76 |
Net Income to Common | -29.44 | -29.67 | -30.02 | -33.97 | -30.59 | -8.33 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 103 | 66 | 28 | 26 | 24 | 20 |
Shares Outstanding (Diluted) | 103 | 66 | 28 | 26 | 24 | 20 |
Shares Change | 238.18% | 132.26% | 11.65% | 7.09% | 21.93% | -58.34% |
EPS (Basic) | -0.41 | -0.45 | -1.05 | -1.33 | -1.28 | -0.43 |
EPS (Diluted) | -0.41 | -0.45 | -1.05 | -1.33 | -1.28 | -0.43 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | - | -18.8 | -35.76 | -52.47 | -48.13 | -32.75 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | - | -0.28 | -1.26 | -2.06 | -2.02 | -1.68 |
Gross Margin | 100.00% | 100.00% | 100.00% | - | - | 100.00% |
Operating Margin | -1092.96% | -2345.99% | -5186.19% | - | - | -1899.12% |
Profit Margin | -1143.17% | -2507.65% | -5504.28% | - | - | -1953.92% |
FCF Margin | - | -1151.38% | -3478.99% | - | - | -1205.41% |
EBITDA | -34.64 | -37.41 | -52.29 | -65.28 | -62.9 | -51.1 |
EBITDA Margin | -1092.96% | -2290.88% | -5086.19% | - | - | -1880.82% |
EBIT | -34.64 | -38.31 | -53.31 | -66.1 | -63.45 | -51.6 |
EBIT Margin | -1092.96% | -2345.99% | -5186.19% | - | - | -1899.12% |
Effective Tax Rate | - | 0.00% | 0.00% | 0.00% | 0.11% | 0.08% |